Corcept Therapeutics Stock (NASDAQ: CORT) stock price, news, charts, stock research, profile.
Open | $22.280 |
Close | - |
Volume / Avg. | 428.471K / 1.189M |
Day Range | 22.280 - 23.220 |
52 Wk Range | 20.840 - 34.275 |
Market Cap | $2.379B |
P/E Ratio | 23.628 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 44 |
Short Interest | 28.95% |
Days to Cover | 25.23 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Corcept Therapeutics (NASDAQ: CORT) through any online brokerage.
Other companies in Corcept Therapeutics’s space includes: Supernus Pharmaceuticals (NASDAQ:SUPN), Tarsus Pharmaceuticals (NASDAQ:TARS), Neumora Therapeutics (NASDAQ:NMRA), ANI Pharmaceuticals (NASDAQ:ANIP) and Axsome Therapeutics (NASDAQ:AXSM).
The latest price target for Corcept Therapeutics (NASDAQ: CORT) was reported by HC Wainwright & Co. on Tuesday, April 23, 2024. The analyst firm set a price target for 38.00 expecting CORT to rise to within 12 months (a possible 65.87% upside). 13 analyst firms have reported ratings in the last year.
The stock price for Corcept Therapeutics (NASDAQ: CORT) is $22.91 last updated Today at April 26, 2024 at 3:07 PM EDT.
There are no upcoming dividends for Corcept Therapeutics.
Corcept Therapeutics’s Q1 earnings are confirmed for Wednesday, May 1, 2024.
There is no upcoming split for Corcept Therapeutics.
Corcept Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.